NCT07334041

Brief Summary

The objective of this physiological study is to compare two preoxygenation techniques (non-invasive ventilation combined with high-flow nasal oxygen versus non-invasive ventilation alone) by monitoring end-tidal oxygen fraction (FeO₂) and the Oxygen Reserve Index (ORI) during 3 minutes of preoxygenation in healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 9, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2026

Completed
Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

December 30, 2025

Last Update Submit

May 12, 2026

Conditions

Keywords

PreoxygenationHigh flow nasal cannulaNon-invasive ventilationHealthy volunteersNoninvasive Ventilation

Outcome Measures

Primary Outcomes (1)

  • Change in end-tidal oxygen fraction (FeO2) at the end of each preoxygenation technique

    FeO2 will be collected every 12 seconds during preoxygenation. The mean FeO2 value at 3 minutes will be used for comparison between techniques.

    3 minutes

Secondary Outcomes (9)

  • Change in end-tidal oxygen fraction (FeO2) during each preoxygenation technique

    3 minutes

  • Maximum FeO2 value

    3 minutes

  • Average Oxygen Reserve Index (ORI) value

    3 minutes

  • Maximum ORI value

    3 minutes

  • Change in ORI during each preoxygenation technique

    3 minutes

  • +4 more secondary outcomes

Study Arms (2)

Non-invasive ventilation combined to high flow nasal cannula

EXPERIMENTAL

\- NIV + HFNC: Non-invasive ventilation in pressure-controlled mode with inspiratory pressure adjusted to achieve a tidal volume of 6-8 mL/kg (in practice, inspiratory pressure between 5 and 10 cmH₂O) and a PEEP of 5 cmH₂O, combined with high-flow nasal cannula oxygen at 60 L/min with an FiO₂ of 100%

Other: Preoxygenation with VNI + OHD

Non invasive ventilation

EXPERIMENTAL

\- NIV alone in pressure-controlled mode with inspiratory pressure adjusted to achieve a tidal volume of 6-8 mL/kg (in practice, inspiratory pressure between 5 and 10 cmH₂O) and a PEEP of 5 cmH₂O

Other: Preoxygenation with VNI

Interventions

Each preoxygenation session will last 3 minutes with the participant positioned at a 30° head-up angle. A washout period of 10 minutes will be applied between each preoxygenation session, and initiation of the second preoxygenation technique will require the Oxygen Reserve Index (ORI) to return to 0. Monitoring will include: * Oxygen Reserve Index (ORI) * End-tidal oxygen fraction (FeO₂) measured at the NIV mask * Peripheral oxygen saturation (SpO₂)

Non-invasive ventilation combined to high flow nasal cannula

Each preoxygenation session will last 3 minutes with the participant positioned at a 30° head-up angle. A washout period of 10 minutes will be applied between each preoxygenation session, and initiation of the second preoxygenation technique will require the Oxygen Reserve Index (ORI) to return to 0. Monitoring will include: * Oxygen Reserve Index (ORI) * End-tidal oxygen fraction (FeO₂) measured at the NIV mask * Peripheral oxygen saturation (SpO₂)

Non invasive ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female
  • Healthy volunteer who has provided written informed consent
  • Age \> 18 years

You may not qualify if:

  • Long-term oxygen therapy
  • Cardiac or pulmonary disease (including asthma)
  • Presence of Raynaud's syndrome
  • Claustrophobia
  • Body mass index (BMI) ≥ 30 kg/m²
  • Presence of nail polish preventing accurate SpO₂ and ORI measurement
  • Under legal protection
  • Incarcerated individuals
  • Persons deprived of liberty
  • Not affiliated to French social security
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Orléans

Orléans, 45067, France

Location

Study Officials

  • Mai-Anh NAH, MD

    CHU d'Orléans

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Randomized interventional crossover study comparing two preoxygenation techniques in healthy volunteers.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2025

First Posted

January 12, 2026

Study Start

March 9, 2026

Primary Completion

April 29, 2026

Study Completion

April 29, 2026

Last Updated

May 14, 2026

Record last verified: 2026-05

Locations